Public health research · Heidelberg, Mainz & Munich

Researching heart failure across disciplines: multimodal AI, exercise training and robotics for innovative therapy

Multi-dimensionAI links different scales of health information to investigate patterns in HFpEF and differences between patients.

Funded by
Carl-Zeiss-Stiftung
Funding amount
Approximately
€5 million
Project period
July 2024
to June 2030
Locations
Heidelberg, Mainz
& Munich

Heart failure with preserved ejection fraction (HFpEF) affects approximately half of all patients with heart failure and is associated with substantial morbidity and mortality. As a complex multisystem disease characterised by heterogeneous clinical phenotypes, HFpEF presents considerable challenges for diagnosis and treatment. Advances in artificial intelligence (AI) offer new opportunities to improve disease characterisation and develop personalised treatment strategies.

The Multi-dimensionAI project brings together interdisciplinary expertise across three interconnected subprojects. Its overarching innovation lies in integrating AI-driven disease phenotyping, prospective clinical intervention data, and stakeholder-centred evaluation within a unified framework.

By linking existing and newly collected molecular, clinical, imaging and wearable-derived data across different scales, the project aims to uncover previously unrecognised disease patterns and identify patient subgroups that may benefit from tailored interventions.

Patients and healthcare professionals are involved in the development process at an early stage. Their active participation is intended to ensure that the AI technologies developed are trustworthy, prove themselves in everyday clinical practice and can be used meaningfully in future care.

HFpEF (heart failure with preserved ejection fraction) is a common form of chronic heart failure. Relaxation and filling of the left ventricle are often impaired, while the proportion of blood it ejects with each beat remains preserved.

Causes, accompanying conditions, disease progression and response to therapy can differ substantially between patients.

This heterogeneity makes prognosis and treatment decisions difficult. Multi-dimensionAI investigates how different sources of information might help researchers better understand these differences in the future.

“Multimodal” means bringing together information from different sources for AI-supported research analysis. The aim is to search for recurring patterns and possible correlations, not to make an automated diagnosis.

The exercise-and-coaching study and the robotics-assisted study ask related questions, but they are separate.

A two-centre study comparing standard HFpEF care with standard care plus a 12-week individual training programme and app-based personalised activity coaching.

DRKS00039892 · Recruiting in Mainz and Heidelberg

An individually adapted exosuit or exoskeleton can support movement during supervised training. The project investigates which patients may benefit from exercise therapy based on combinations of characteristics.

Recruitment status not yet confirmed · study details to follow
Supervised treadmill training with movement-support equipment
Institutional context

Team & partners

All PIs & institutions →
Funded by
Carl-Zeiss-Stiftung
Get in touch

Connect with Multi-dimensionAI

For scientific exchange, cooperation enquiries or further information about the project, contact the research team.

Contact the team